
Highlight Therapeutics
Developer of RNA-based immuno-oncology therapies designed to combat cancer in patients. The company's therapies recapitulate the effect of viral infection and enhance the therapeutic effect of drugs, ...
Valuation
$0
Share Price
N/A
Total Raised
$76.2M
Last Round
N/A